Henry Schein (NASDAQ:HSIC) Updates Q4 2024 Earnings Guidance

Henry Schein (NASDAQ:HSIC) issued an update on its fourth quarter 2024 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 1.190-1.190 for the period, compared to the consensus earnings per share estimate of 1.230. The company issued revenue guidance of $3.2 billion-$3.2 billion, compared to the consensus revenue estimate of $3.3 billion. Henry Schein also updated its FY 2024 guidance to 4.740-4.740 EPS.

Analyst Ratings Changes

A number of analysts have issued reports on the company. Mizuho began coverage on Henry Schein in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 target price for the company. Barrington Research boosted their price objective on Henry Schein from $82.00 to $90.00 and gave the company an “outperform” rating in a research note on Thursday. Evercore ISI lifted their target price on shares of Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 8th. Jefferies Financial Group upped their price target on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research note on Thursday, January 23rd. Finally, Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and boosted their target price for the company from $69.00 to $84.00 in a report on Monday, January 6th. Seven equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, Henry Schein has a consensus rating of “Moderate Buy” and an average target price of $80.10.

Henry Schein Stock Up 0.2 %

NASDAQ HSIC opened at $80.03 on Friday. Henry Schein has a 1 year low of $63.67 and a 1 year high of $82.63. The stock has a market capitalization of $9.98 billion, a PE ratio of 32.93, a PEG ratio of 2.20 and a beta of 0.89. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The business’s 50-day moving average is $73.31 and its 200 day moving average is $71.34.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, beating analysts’ consensus estimates of $1.17 by $0.05. The company had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm’s revenue for the quarter was up .4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.32 earnings per share. Sell-side analysts forecast that Henry Schein will post 4.74 earnings per share for the current year.

Insiders Place Their Bets

In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of Henry Schein stock in a transaction on Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the transaction, the chief operating officer now owns 87,706 shares in the company, valued at approximately $6,577,950. The trade was a 12.25 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.14% of the stock is currently owned by company insiders.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.